Universidade Estadual Paulista - UNESP, Ilha Solteira, Brazil.
Universidade do Grande Rio - UNIGRANRIO, Duque de Caxias, Brazil.
Oral Maxillofac Surg. 2021 Dec;25(4):541-547. doi: 10.1007/s10006-021-00940-4. Epub 2021 Mar 13.
This study aimed to compare the three-dimensional volumetric changes of human maxillary sinuses after reconstruction using 5 different bone grafts.
Patients underwent unilateral maxillary sinus bone height reconstruction using 5 bone substitutes allocated in different groups as follows: group 1 was grafted with autogenous bone graft alone; group 2 with beta-tricalcium phosphate (β-TCP); group 3 with β-TCP + autogenous bone graft 1:1; group 4 with bioactive glass; and group 5 with bioactive glass + autogenous bone graft 1:1. The patients were submitted to cone beam computed tomography in two periods: 15 days after the surgical procedure (T1) and after 6 months (T2). The results were evaluated as the formula T2-T1 expressing the three-volumetric changes of the biomaterials in elapsed time.
The resorption rate of autogenous bone graft was -630.699 ± 300.9 mm; in the β-TCP group, it was -315.772 ± 125.6 mm; in the group with β-TCP + autogenous bone graft 1:1, it was -336.205 ± 195.7 mm; and in groups with bioactive glass and with the addition of autogenous bone graft 1:1, it was -428.878 ± 311.6 mm and -576.917 ± 471.6 mm, respectively, without statistical difference (p = 0.167). Pearson's correlated test revealed a strong correlation as well as a progressive resorption of the grafts during bone healing.
The similar outcomes for the three-dimensional volumetric changes using the bone substitutes evaluated after 6 months of bone healing suggest that all these grafts can be performed to maxillary sinus reconstruction.
本研究旨在比较 5 种不同骨移植物重建人上颌窦后三维容积变化。
患者接受单侧上颌窦骨高度重建,5 种骨替代物分别分配到不同组如下:组 1 单纯自体骨移植;组 2 磷酸三钙(β-TCP);组 3 β-TCP+自体骨 1:1;组 4 生物活性玻璃;组 5 生物活性玻璃+自体骨 1:1。患者在两个时期接受锥形束 CT 检查:手术 15 天后(T1)和 6 个月后(T2)。结果以公式 T2-T1 表示生物材料在时间流逝中的三维体积变化。
自体骨移植的吸收率为-630.699±300.9mm;β-TCP 组为-315.772±125.6mm;β-TCP+自体骨 1:1 组为-336.205±195.7mm;生物活性玻璃组和添加自体骨 1:1 组分别为-428.878±311.6mm 和-576.917±471.6mm,差异无统计学意义(p=0.167)。Pearson 相关检验显示,随着骨愈合,移植物具有较强的相关性和渐进性吸收。
6 个月骨愈合后评估的骨替代物三维容积变化相似,表明所有这些移植物均可用于上颌窦重建。